Outset Medical Inc Market Cap ($76.88 Million)
Market Cap & Net Worth: Outset Medical Inc (OM)
Outset Medical Inc market cap. Outset Medical Inc (NASDAQ:OM) has a market capitalization of $76.88 Million ($76.88 Million) as of November 5, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #20059 globally and #4590 in its home market, demonstrating a 2.30% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Outset Medical Inc's stock price $4.44 by its total outstanding shares 18797164 (18.80 Million). Also see how efficiently does Outset Medical Inc generate cash for how efficiently the company converts equity into cash flow.
Outset Medical Inc Market Cap History (2020–2026)
Outset Medical Inc market cap history from 2020 to 2026. Data shows change from $1.07 Billion to $83.46 Million (-34.68% CAGR). Check Outset Medical Inc stock quote for real-time trading data and today's change.
Index Memberships
Outset Medical Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.62 Trillion | 0.00% | #560 of 976 |
|
NASDAQ Composite
IXIC
|
$40.12 Trillion | 0.00% | #1922 of 3165 |
Weight: Outset Medical Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Outset Medical Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Outset Medical Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Outset Medical Inc (OM) equity growth momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.58x
Outset Medical Inc's market cap is 0.58 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $1.07 Billion | $49.94 Million | -$120.70 Million | 21.40x | N/A |
| 2021 | $866.36 Million | $102.60 Million | -$131.94 Million | 8.44x | N/A |
| 2022 | $485.34 Million | $115.38 Million | -$162.96 Million | 4.21x | N/A |
| 2023 | $101.69 Million | $130.38 Million | -$172.80 Million | 0.78x | N/A |
| 2024 | $20.86 Million | $113.69 Million | -$127.98 Million | 0.18x | N/A |
| 2025 | $69.74 Million | $119.48 Million | -$81.65 Million | 0.58x | N/A |
Competitor Companies of OM by Market Capitalization
Companies near Outset Medical Inc in the global market cap rankings as of November 5, 2026. Also see Outset Medical Inc total assets for a full breakdown of the balance sheet.
Key companies related to Outset Medical Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #107 globally with a market cap of $196.11 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #182 globally with a market cap of $130.04 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #225 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #237 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #107 | Abbott Laboratories | NYSE:ABT | $196.11 Billion | $115.51 |
| #182 | Stryker Corporation | NYSE:SYK | $130.04 Billion | $339.65 |
| #225 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $104.96 |
| #237 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of Outset Medical Inc (2020–2026)
Market capitalization of Outset Medical Inc from 2020 to today. Between 2020 and today, Outset Medical Inc's market cap moved from $1.07 Billion to $ 83.46 Million, with a yearly change of -34.68%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $83.46 Million | +19.68% |
| 2025 | $69.74 Million | +234.23% |
| 2024 | $20.86 Million | -79.48% |
| 2023 | $101.69 Million | -79.05% |
| 2022 | $485.34 Million | -43.98% |
| 2021 | $866.36 Million | -18.91% |
| 2020 | $1.07 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 5th, 2026 the market cap of Outset Medical Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $76.88 Million USD |
| MoneyControl | $76.88 Million USD |
| MarketWatch | $76.88 Million USD |
| marketcap.company | $76.88 Million USD |
| Reuters | $76.88 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Outset Medical Inc
Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company provides Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge… Read more